Puma Biotechnology Inc
General ticker "PBYI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $148.3M
Puma Biotechnology Inc does not follow the US Stock Market performance with the rate: -31.9%.
Estimated limits based on current volatility of 3.0%: low 2.74$, high 2.91$
Factors to consider:
- Current price 12.7% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.22$, 5.94$]
- 2024-12-30 to 2025-12-30 estimated range: [3.59$, 6.48$]
Short-term PBYI quotes
Long-term PBYI plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $235.64MM |
| Operating Expenses | $203.00MM |
| Operating Income | $32.64MM |
| Non-Operating Income | $-9.97MM |
| Interest Expense | $13.33MM |
| R&D Expense | $50.38MM |
| Income(Loss) | $22.67MM |
| Taxes | $1.08MM |
| Profit(Loss) | $21.59MM |
| Stockholders Equity | $53.44MM |
| Inventory | $7.08MM |
| Assets | $230.53MM |
| Operating Cash Flow | $27.01MM |
| Capital expenditure | $12.64MM |
| Investing Cash Flow | $-19.12MM |
| Earnings Per Share* | $0.46 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.